与小分子和氧醇的GPR17结构和激素作用
bioRxiv : the preprint server for biology
|December 15, 2025
概括
GPR17对抗性提供了潜在的复髓化疗法. 新的结构揭示了 Orthosteric 连接体结合有限的口袋,而内源性激动剂则以Allosteric 作用,这表明了新的药物发现途径.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 结构生物学 结构生物学
背景情况:
- G蛋白结合受体17 (GPR17) 是中枢神经系统髓化的一个关键调节器.
- 抑制 GPR17 是促进复髓化的一种治疗策略.
- 了解GPR17对联体结合的结构基础对于药物发现至关重要.
研究的目的:
- 确定GPR17激动性和对抗性的结构基础.
- 为GPR17向治疗提供合理的药物发现信息.
主要方法:
- 低温电子显微镜 (cryo-EM) 用于获得新的GPR17结构.
- 生物物理和细胞对连接体结合和功能的特征.
- 药理学和光亲和性标签研究.
主要成果:
- 新的冷-EM结构揭示了GPR17与G蛋白复合的奥托斯特抗体或激动剂结合.
- 这两种 Orthosteric 连接体都结合于一个受限制的口袋的侧边缘,由一条延长的细胞外环所限制.
- 发现内源性氧醇激动剂可以结合全性,而不是与正性结合物.
结论:
- GPR17的正性结合部位在结构上受到限制,限制了强大的正性结合物的发展.
- 对GPR17的向性向是开发对抗剂的有希望的替代策略.
- 这些发现为推进基于GPR17的神经系统疾病的治疗方法提供了关键的见解.
相关概念视频
G Protein-coupled Receptors
16.3K
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
16.3K
Transducer Mechanism: G Protein–Coupled Receptors
3.9K
G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical,...
GPCRs are also called heptahelical,...
3.9K
Opioid Receptors: Overview
3.9K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
3.9K
Drug-Receptor Interaction: Agonist
3.7K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
3.7K
The Two-State Receptor Model
3.0K
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
The binding affinity of a drug determines its interaction with...
3.0K
GPCR Desensitization
7.9K
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
7.9K


